已收录 271055 条政策
 政策提纲
  • 暂无提纲
Effect of [1, 3-Di-n-Butyl-7-(2-Oxopropyl)-Xanthine] (Denbufylline), a Low Km Phosphodiesterase Inhibitor, on Striatal Acetylcholine Release in the Rat: Analysis Using Cerebral Microdialysis
[摘要] References(27)Cited-By(2)Effect of oral and intraperitoneal administrations of [1, 3-di-n-butyl-7-(2-oxopropyl)-xanthine] (denbufylline) on acetylcholine (ACh) content and release in the rat striatum was investigated. Denbufylline (3, 10 and 30 mg/kg, p.o.) decreased striatal ACh contents in a dose-dependent manner. Denbufylline administration (30 mg/kg, i.p.) produced no significant change in the spontaneous release of ACh, while it increased a high potassium-evoked ACh release in the striatum. These results suggest that denbufylline may be a drug inducing the increased release of ACh in the brain.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文